Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 3.28% | 61.09 | 0.0% | $918.14m | |
| NVAX | Novavax, Inc. | 31.62% | 104.56 | 102.0% | $825.80m | |
| AMGN | Amgen, Inc. | -1.21% | 253.15 | 1.3% | $733.54m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.17% | 640.88 | 2.5% | $687.80m | |
| GILD | Gilead Sciences, Inc. | -0.44% | 76.42 | 1.0% | $676.56m | |
| BIIB | Biogen, Inc. | -0.54% | 268.35 | 1.6% | $573.84m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.66% | 299.06 | 1.9% | $522.97m | |
| ILMN | Illumina, Inc. | -1.92% | 372.12 | 3.5% | $297.26m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.98% | 112.46 | 2.0% | $230.21m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.21% | 127.98 | 4.3% | $212.65m | |
| SGEN | Seattle Genetics, Inc. | 3.34% | 176.14 | 6.1% | $207.80m | |
| SRNE | Sorrento Therapeutics, Inc. | 3.00% | 7.38 | 1.8% | $195.17m | |
| IMMU | Immunomedics, Inc. | 1.30% | 41.16 | 11.0% | $178.10m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.25% | 163.89 | 13.9% | $167.23m | |
| INCY | Incyte Corp. | 0.80% | 108.65 | 2.5% | $166.01m |
Company Profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.